Home LiteratureArticle Details
PMID: 18077787 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production.

Blood ·Vol. 111 ·No. 4 ·2008-02-15 ·Pages 2158-62

Lang GA, Devera TS, Lang ML

Abstract

Activation of natural killer-like T (NKT) cells with the CD1d ligand alpha-galactosylceramide enhances T-dependent humoral immune responses against coadministered T-dependent Ag. At present, there is little information on the mechanisms involved other than a dependence on CD1d expression by antigen-presenting cells and/or development of the NKT subset. We therefore tested the hypothesis that direct presentation of alpha-GC by B cells was required for NKT-enhanced Ab responses against T-dependent Ag. We reconstituted B cell-deficient microMT mice with B cells from C57Bl/6 donors or CD1d(-/-) donors before immunization with NP-KLH alone or NP-KLH mixed with alpha-GC. We made the surprising observation that B-cell expression of CD1d is absolutely required for the NKT-enhanced Ab response. Our data show that the mechanism by which NKT cells enhance humoral immune responses involves interaction with CD1d-expressing B cells.

MeSH Terms
Adoptive Transfer Animals Antibody Formation Antigens, CD/immunology Antigens, CD1/genetics,immunology Antigens, CD1d B-Lymphocytes/immunology Galactosylceramides/pharmacology Humans Killer Cells, Natural/drug effects,immunology Lymphocyte Activation/drug effects Mice Mice, Knockout Spleen/immunology Thymus Gland/immunology
Chemicals
Antigens, CD Antigens, CD1 Antigens, CD1d CD1D protein, human Galactosylceramides alpha-galactosylceramide
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Lang Gillian A
Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Devera T Scott
Lang Mark L
References (23)
23 references, click to expand
  1. Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells.
    J Immunol. 2007 Mar 1;178(5):2721-9 PMID: 17312114
  2. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
    Cell Immunol. 2000 Jan 10;199(1):37-42 PMID: 10675273
  3. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.
    J Exp Med. 2003 Jul 21;198(2):267-79 PMID: 12874260
  4. CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
    J Exp Med. 2003 Apr 21;197(8):1051-7 PMID: 12695492
  5. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells.
    Science. 1999 Jan 8;283(5399):225-9 PMID: 9880256
  6. Infection-induced marginal zone B cell production of Borrelia hermsii-specific antibody is impaired in the absence of CD1d.
    J Immunol. 2005 May 1;174(9):5681-6 PMID: 15843569
  7. alpha-Galactosylceramide can act as a nasal vaccine adjuvant inducing protective immune responses against viral infection and tumor.
    J Immunol. 2005 Sep 1;175(5):3309-17 PMID: 16116223
  8. Immunization with alpha-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis.
    Eur J Immunol. 1999 Jun;29(6):2014-25 PMID: 10382765
  9. NKT cells: what's in a name?
    Nat Rev Immunol. 2004 Mar;4(3):231-7 PMID: 15039760
  10. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
    Immunology. 2006 Sep;119(1):116-25 PMID: 16792697
  11. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids.
    Annu Rev Immunol. 1999;17:297-329 PMID: 10358761
  12. Innate immune response to encephalomyocarditis virus infection mediated by CD1d.
    Immunology. 2003 Dec;110(4):519-26 PMID: 14632651
  13. Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo.
    J Immunol. 2005 Apr 15;174(8):4696-705 PMID: 15814694
  14. Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype.
    J Immunol. 1999 Sep 1;163(5):2373-7 PMID: 10452969
  15. NKT cells: facts, functions and fallacies.
    Immunol Today. 2000 Nov;21(11):573-83 PMID: 11094262
  16. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds?
    Immunol Cell Biol. 2004 Jun;82(3):285-94 PMID: 15186260
  17. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.
    Nat Immunol. 2002 Sep;3(9):867-74 PMID: 12154358
  18. Invariant NKT cells sustain specific B cell responses and memory.
    Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3984-9 PMID: 17360464
  19. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model.
    J Immunol. 2003 Aug 15;171(4):1637-41 PMID: 12902459
  20. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells.
    J Exp Med. 1999 Sep 20;190(6):783-92 PMID: 10499917
  21. Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice.
    J Exp Med. 2003 Apr 21;197(8):997-1005 PMID: 12695491
  22. Cutting edge: antibody production to pneumococcal polysaccharides requires CD1 molecules and CD8+ T cells.
    J Immunol. 2005 Feb 15;174(4):1787-90 PMID: 15699104
  23. Cutting edge: CD1d deficiency impairs murine host defense against the spirochete, Borrelia burgdorferi.
    J Immunol. 2000 Nov 1;165(9):4797-801 PMID: 11046002
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
2008-02-15
Epub
2007-00-12
Pages
2158-62
Language
English
Region
United States
NLM ID
7603509
PMCID
PMC2234052
Subset
IM
Grants
NCRR NIH HHS · P20 RR015564 · United States
NCRR NIH HHS · 5P20RR015564-07 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com